MEI Pharma Inc (MEIP)

Name: MEI Pharma Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$0.0

Net Income

-$30.8M

Operating Margin

N/A

Free Cash Flow

-$20.8M

Debt / Assets

7.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for MEI Pharma Inc (MEIP).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-03-31	2024-12-31
Revenue	0	0	0	0
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	3,305,000	2,998,000	2,405,000	3,143,000
Operating Expenses	3,351,000	3,008,000	2,774,000	3,451,000
Operating Income	-3,351,000	-3,008,000	-2,774,000	-3,451,000
Interest Expense	0	0	0	0
Income Before Tax	-30,799,000	-3,639,000	-2,573,000	-2,677,000
Income Tax Expense	0	0	0	0
Net Income	-30,799,000	-3,639,000	-2,573,000	-2,677,000
Per Share
EPS	-4.62	-0.55	-0.39	-0.40
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for MEI Pharma Inc (MEIP).
Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Revenue	0	65,297,000	48,816,000	40,697,000	25,535,000
Cost of Revenue	368,000	383,000	1,815,000	1,235,000	1,408,000
Gross Profit	-368,000	64,914,000	47,001,000	39,462,000	24,127,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	13,532,000	23,295,000	33,130,000	30,540,000	24,414,000
Operating Expenses	17,087,000	50,755,000	85,580,000	116,181,000	93,812,000
Operating Income	-17,455,000	14,542,000	-36,764,000	-75,484,000	-69,685,000
Interest Expense	0	0	0	284,000	0
Income Before Tax	-15,945,000	17,778,000	-31,838,000	-54,454,000	-50,567,000
Income Tax Expense	0	0	-4,948,000	284,000	8,000
Net Income	-15,945,000	17,778,000	-31,840,000	-54,738,000	-50,575,000
Per Share
EPS	-2.39	2.67	-4.78	-8.80	-0.45
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for MEI Pharma Inc (MEIP).
Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Assets
Cash and Cash Equivalents	18,011,000	3,705,000	16,906,000	15,740,000
Short Term Investments	0	34,640,000	83,787,000	137,512,000
Net Receivables	0	0	85,000	10,044,000
Inventory	0	0	0	1
Total Current Assets	18,285,000	40,769,000	107,528,000	167,126,000
Property Plant Equipment	0	606,000	13,281,000	10,714,000
Goodwill and Intangibles	0	0	0	0
Total Assets	18,285,000	41,375,000	120,809,000	177,840,000
Liabilities
Account Payables	176,000	3,168,000	6,134,000	7,918,000
Short Term Debt	0	0	1,428,000	871,000
Total Current Liabilities	1,354,000	8,355,000	20,340,000	24,443,000
Long Term Debt	0	0	11,300,000	8,771,000
Total Liabilities	1,354,000	8,355,000	96,185,000	125,427,000
Shareholders Equity
Retained Earnings	-404,164,000	-388,219,000	-405,997,000	-374,159,000
Total Shareholders Equity	16,931,000	33,020,000	24,624,000	52,413,000

Balance sheet annual history for MEI Pharma Inc (MEIP).
Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Assets
Cash and Cash Equivalents	18,011,000	3,705,000	16,906,000	15,740,000	8,543,000
Short Term Investments	0	34,640,000	83,787,000	137,512,000	144,883,000
Net Receivables	0	0	85,000	10,044,000	7,582,000
Inventory	0	0	0	1	0
Total Current Assets	18,285,000	40,769,000	107,528,000	167,126,000	164,817,000
Property Plant Equipment	0	606,000	13,281,000	10,714,000	9,281,000
Goodwill and Intangibles	0	0	0	0	0
Total Assets	18,285,000	41,375,000	120,809,000	177,840,000	174,098,000
Liabilities
Account Payables	176,000	3,168,000	6,134,000	7,918,000	6,355,000
Short Term Debt	0	0	1,428,000	871,000	928,000
Total Current Liabilities	1,354,000	8,355,000	20,340,000	24,443,000	30,294,000
Long Term Debt	0	0	11,300,000	8,771,000	7,370,000
Total Liabilities	1,354,000	8,355,000	96,185,000	125,427,000	132,736,000
Shareholders Equity
Retained Earnings	-404,164,000	-388,219,000	-405,997,000	-374,159,000	-327,809,000
Total Shareholders Equity	16,931,000	33,020,000	24,624,000	52,413,000	41,362,000

Cash flow quarterly history for MEI Pharma Inc (MEIP).
Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30	2022-06-30
Operating Activities
Net Income	-15,945,000	17,778,000	-31,838,000	-54,454,000
Depreciation & Amortization	368,000	383,000	386,000	326,000
Stock Based Compensation	-144,000	2,278,000	3,589,000	8,350,000
Change in Working Capital	-4,851,000	-84,276,000	-24,947,000	16,875,000
Operating Cash Flow	-20,844,000	-50,473,000	-52,484,000	-48,746,000
Investing Activities
Capital Expenditure	0	-7,000	-35,000	-479,000
Investments	0	-7,000	-35,000	-479,000
Investing Cash Flow	35,150,000	49,140,000	53,690,000	6,892,000
Financing Activities
Debt Repayment	0	0	0	0
Common Stock Issued/Repurchased	0	0	-40,000	52,131,000
Dividends Paid	0	-11,660,000	0	0
Financing Cash Flow	0	-11,868,000	-40,000	49,051,000
Summary
Free Cash Flow	-20,844,000	-50,480,000	-52,519,000	-49,225,000
Net Change in Cash	14,306,000	-13,201,000	1,166,000	7,197,000

Cash flow annual history for MEI Pharma Inc (MEIP).
Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30	2022-06-30	2021-06-30
Operating Activities
Net Income	-15,945,000	17,778,000	-31,838,000	-54,454,000	-50,575,000
Depreciation & Amortization	368,000	383,000	386,000	326,000	285,000
Stock Based Compensation	-144,000	2,278,000	3,589,000	8,350,000	10,245,000
Change in Working Capital	-4,851,000	-84,276,000	-24,947,000	16,875,000	26,203,000
Operating Cash Flow	-20,844,000	-50,473,000	-52,484,000	-48,746,000	-31,964,000
Investing Activities
Capital Expenditure	0	-7,000	-35,000	-479,000	-708,000
Investments	0	-7,000	-35,000	-479,000	-708,000
Investing Cash Flow	35,150,000	49,140,000	53,690,000	6,892,000	24,708,000
Financing Activities
Debt Repayment	0	0	0	0	0
Common Stock Issued/Repurchased	0	0	-40,000	52,131,000	3,136,000
Dividends Paid	0	-11,660,000	0	0	0
Financing Cash Flow	0	-11,868,000	-40,000	49,051,000	3,468,000
Summary
Free Cash Flow	-20,844,000	-50,480,000	-52,519,000	-49,225,000	-32,672,000
Net Change in Cash	14,306,000	-13,201,000	1,166,000	7,197,000	-3,788,000